EUVIMEDEUVIMED entdecken
Crossref

Phototherapy for atopic dermatitis: A survey of European practice

M Steyn, L A A Gerbens, P I Spuls, S Mashayekhi, M Deleuran iD, S Barbarot iD, A Wollenberg iD, J Ferguson, S Ibbotson iD, C Flohr iD

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.19638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von M Steyn und 9 weiteren Autor:innen. Beteiligte Einrichtung: St John's Institute for Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Ultraviolet Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phototherapy is used to treat atopic dermatitis (AD). Evidence for its efficacy, impact on quality of life, cost‐effectiveness and short‐ and long‐term safety with real‐life usage is weak.

Objectives

We established a taskforce to examine how phototherapy is currently being used as a treatment for AD across the United Kingdom and Europe to inform our understanding and guide future research into management of patients with AD using UV‐based phototherapies.

Methods

An anonymous electronic multiple‐response survey exploring phototherapy prescribing practices and experience of phototherapy modalities was developed by the study authors and sent to members of phototherapy networks from the United Kingdom and Europe. Responses were received between February and July 2021.

Results

About 144 respondents from 27 European countries completed the survey. NBUVB was the most widely used [ n = 138 (96%)]. Home‐based NBUVB was available in 8/27 countries (25/144 respondents, 17%). Oral psoralen‐UVA (PUVA) was more widely available than bath PUVA ( n = 106, 74% vs. n = 60, 42%) and used mainly in adult patients. 49/144 (34%) of respondents had access to UVA1. Phototherapy would be considered instead of systemic treatment in 96% of adults and 82% of children for NBUVB, versus 40% of adults and 3% of children for PUVA. Starting doses, standard dosing increments, length of treatment courses, lifetime limits for treatments and thresholds for performing annual skin assessments varied between responders.

Conclusions

NBUVB was the most widely used phototherapy for AD in adult and paediatric patients, while PUVA and UVA1 were less used. Prescribing practices varied considerably, highlighting the lack of consensus practice in many different aspects of phototherapy for the treatment of AD in children and adults. This indicates that further studies are required to determine optimal phototherapeutic regimens for AD and informs our understanding of parameters that should be included in future high‐quality randomized controlled trials (RCT) of phototherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicUltraviolet TherapyAdultHumansChildPhototherapyEuropeUnited Kingdom

Autor:innen und Institutionen

  • St John's Institute for Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Department of Dermatology, Amsterdam UMC, Academic Medical Center, Amsterdam Public Health, Infection and Immunity, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Dermatology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
  • Department of Dermatology, CHU Nantes, Nantes Université, UMR 1280 PhAN, INRA, Nantes, France.
  • Department of Dermatology and Allergy, Augsburg University Hospital, Augsburg, Germany.
  • Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany.

ORCID-Profile: M Deleuran, S Barbarot, A Wollenberg, S Ibbotson, C Flohr

Zitieren

APA

Steyn, M., Gerbens, L. A. A., Spuls, P. I., Mashayekhi, S., Deleuran, M., Barbarot, S., Wollenberg, A., Ferguson, J., Ibbotson, S., & Flohr, C. (2024). Phototherapy for atopic dermatitis: A survey of European practice. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19638

Vancouver

Steyn M, Gerbens LAA, Spuls PI, Mashayekhi S, Deleuran M, Barbarot S, et al. Phototherapy for atopic dermatitis: A survey of European practice. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19638

BibTeX
@article{Steyn2024,
  author = {Steyn, M and Gerbens, L A A and Spuls, P I and Mashayekhi, S and Deleuran, M and Barbarot, S and Wollenberg, A and Ferguson, J and Ibbotson, S and Flohr, C},
  title = {Phototherapy for atopic dermatitis: A survey of European practice},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.19638}
}
Kostenlos starten →